Change Language
Call_us
Erlonat Tablet

Erlonat Tablet

6900 INR/Box

Product Details:

  • Medicine Type Allopathic
  • Molecular Formula C22H23N3O4
  • Dosage 150 mg
  • Storage Store below 30C, protected from moisture
  • Indication Non-Small Cell Lung Cancer and Pancreatic Cancer
  • Dosage Form Tablet
  • CAS No 183319-69-9
  • Click to View more
X

Erlonat Tablet Price And Quantity

  • 100 Box
  • 6900 INR/Box

Erlonat Tablet Product Specifications

  • India
  • Pharmaceutical Grade
  • 30 Tablets
  • 24 Months from date of manufacture
  • Store below 30C, protected from moisture
  • C22H23N3O4
  • 150 mg
  • Allopathic
  • 183319-69-9
  • Non-Small Cell Lung Cancer and Pancreatic Cancer
  • Tablet
  • 99%
  • Hospital, Personal, Clinical
  • White to off-white tablet
  • Erlotinib Hydrochloride

Erlonat Tablet Trade Information

  • Ahmedabad
  • Cash Advance (CA), Cash in Advance (CID)
  • 1000 Box Per Week
  • 1 Week
  • Yes
  • Within a certain price range free samples are available
  • 30 tablets in 1 strip
  • Australia, North America, South America, Eastern Europe, Western Europe, Middle East, Central America, Asia, Africa

Product Description

Erlonat Tablet

Erlonat 150 Tablet should be taken on an empty stomach or should be taken one hour before or 2 hour after meal. You should continue to take it as long as your doctor advises it. The duration of treatment varies according to your needs and response to treatment. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.



Targeted Oncology Therapy

Erlonat Tablet is a specialized therapy developed for patients diagnosed with Non-Small Cell Lung Cancer and Pancreatic Cancer. Designed for oral administration, this medication offers precision in targeting cancer cells and is recommended and dispensed strictly under the supervision of an oncologist.


Strict Prescription and Handling

As a Schedule H medicine, Erlonat Tablet is accessible only with a valid prescription from an accredited oncologist. This regulation ensures controlled dispensing and safe administration for optimal treatment outcomes in hospitals, clinics, and personal care under medical guidance.


Storage and Stability

To maintain potency and integrity, Erlonat Tablet should be stored below 30C and shielded from moisture. With each batch printed on the packaging, patients and healthcare professionals can easily track its manufacturing and expiration details, ensuring safe and reliable usage.

FAQ's of Erlonat Tablet:


Q: How should Erlonat Tablet be taken?

A: Erlonat Tablet should be taken orally as directed by your oncologist, typically on an empty stomach, at least one hour before or two hours after eating. Follow the prescribed dosage and do not alter the regimen without consulting your healthcare provider.

Q: What are the expected benefits of using Erlonat Tablet?

A: Erlonat Tablet is formulated to treat advanced stages of Non-Small Cell Lung Cancer and Pancreatic Cancer. Its targeted action helps inhibit cancer cell growth, potentially slowing disease progression and improving patient outcomes when used as prescribed.

Q: When and where should Erlonat Tablet be stored?

A: Erlonat Tablet must be stored below 30C, away from moisture and direct sunlight. Keep the tablets in their original packaging until use, and store them out of reach of children.

Q: What side effects can Erlonat Tablet cause?

A: Some patients may experience side effects such as diarrhea, rash, or nausea. Contact your healthcare provider if side effects persist or worsen, and always report any serious reactions immediately.

Q: What is the process to obtain Erlonat Tablet?

A: Erlonat Tablet can only be purchased from authorized outlets upon presentation of a prescription issued by an oncologist, in accordance with Schedule H regulations. It is not available over the counter.

Q: Is Erlonat Tablet suitable for personal and clinical usage?

A: Yes, Erlonat Tablet may be administered in hospitals, clinical settings, and, under certain medical guidance, for personal use as prescribed by a licensed oncologist.

Q: How long is Erlonat Tablet safe to use after manufacture?

A: Erlonat Tablet has an expiration date of 24 months from the date of manufacture. Always check the batch number and expiry printed on the packaging before use.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

Other Products in 'Anti Cancer Tablets' category



trade india member
SCHWITZ BIOTECH All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.